Perrigo on Monday announced the appointment of Uwe Röhrhoff as CEO, effective Jan. 15, following the retirement of John Hendrickson.
Teva has re-launched its generic of Ritalin LA (methylphenidate hydrochloride) extended-release capsules. The drug is indicated to treat attention deficit hyperactivity disorder.
“The reintroduction of … is important to Teva’s generic portfolio,” Teva’s COO of North American generics, Maureen Cavanaugh, said. “We continue to be focused on bringing affordable generic treatment options to our customers.”
Aceto’s generics subsidiary Rising Pharmaceuticals has introduced a generic of Bristol Myers Squibb’s Sustiva (efavirenz) capsules. The drug is indicated to treat HIV-1 infections in adults and pediatric patients.
The Port Washington, N.Y.-based company’s generic will be available in 50- and 200-mg dosage strengths. The product had U.S. sales of roughly $4.21 million for the 12 months ended October 2017, according to IQVIA data.